Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

0.3345
Delayed Data
As of Apr 20
 -0.0065 / -1.91%
Today’s Change
0.30
Today|||52-Week Range
3.39
-79.73%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close0.34
Today’s open0.34
Day’s range0.33 - 0.35
Volume1,693,802
Average volume (3 months)2,219,758
Market cap$61.8M
Data as of 3:59pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+77.80%
Earnings growth (this year)+47.98%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IMRNImmuron Ltd-0.50-5.08%
DMPIDelMar Pharmaceutica...+0.03+3.00%
EYEGEyeGate Pharmaceutic...+0.05+9.77%
KTOVKitov Pharma Ltd-0.04-1.54%
Data as of 3:59pm ET, 04/20/2018

Financials

Next reporting dateMay 14, 2018
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$0.00
Annual profit (last year)-$26.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
John Craig Thompson
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts